XRTX
Price:
$1.22
Market Cap:
$3.93M
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medi...[Read more]
Industry
Biotechnology
IPO Date
2021-09-23
Stock Exchange
NASDAQ
Ticker
XRTX
According to XORTX Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.40. This represents a change of -83.36% compared to the average of 8.44 of the last 4 quarters.
The mean historical Current Ratio of XORTX Therapeutics Inc. over the last ten years is 3.20. The current 1.40 Current Ratio has changed 4.29% with respect to the historical average. Over the past ten years (40 quarters), XRTX's Current Ratio was at its highest in in the November 2016 quarter at 24.56. The Current Ratio was at its lowest in in the November 2014 quarter at 0.
Average
3.20
Median
1.09
Minimum
0.03
Maximum
13.80
Discovering the peaks and valleys of XORTX Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.80%
Maximum Annual Current Ratio = 13.80
Minimum Annual Increase = -83.17%
Minimum Annual Current Ratio = 0.03
Year | Current Ratio | Change |
---|---|---|
2023 | 13.80 | 91.75% |
2022 | 7.19 | 88.95% |
2021 | 3.81 | 91.51% |
2020 | 1.99 | 216.95% |
2019 | 0.63 | -42.35% |
2018 | 1.09 | 1.80% |
2017 | 0.06 | 87.29% |
2016 | 0.03 | -83.17% |
The current Current Ratio of XORTX Therapeutics Inc. (XRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.27
5-year avg
5.48
10-year avg
3.20
XORTX Therapeutics Inc.’s Current Ratio is less than Context Therapeutics Inc. (36.91), greater than NeuroSense Therapeutics Ltd. (0.46), greater than Better Therapeutics, Inc. (0.57), less than Quoin Pharmaceuticals, Ltd. (3.02), less than Ensysce Biosciences, Inc. (3.24),
Company | Current Ratio | Market cap |
---|---|---|
36.91 | $104.25M | |
0.46 | $17.52M | |
0.57 | $5.45K | |
3.02 | $2.95M | |
3.24 | $8.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XORTX Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like XORTX Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is XORTX Therapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for XORTX Therapeutics Inc. (XRTX)?
What is the highest Current Ratio for XORTX Therapeutics Inc. (XRTX)?
What is the 3-year average Current Ratio for XORTX Therapeutics Inc. (XRTX)?
What is the 5-year average Current Ratio for XORTX Therapeutics Inc. (XRTX)?
How does the current Current Ratio for XORTX Therapeutics Inc. (XRTX) compare to its historical average?